By promoting RIPK3-MLKL-mediated necroptosis, RIPK3 may be able to limit the occurrence of myeloid leukemia and the differentiation of leukemia initiation cells (Höckendorf et al., 2016). Here, RIPK3 is linked to myeloid leukemia.